Dynamis Therapeutics, Inc. logo

Dynamis Therapeutics, Inc.

Pioneering the future of chronic inflammation treatment through innovative small molecule therapies.

2-10 employees · est. 1997 · Jenkintown, United States

VS
Immunic Therapeutics logo

Immunic Therapeutics

Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases

91 employees · est. 2016 · United States

Dynamis Therapeutics, Inc. is the older company (1997 vs 2016); Immunic Therapeutics is the larger of the two.

Side-by-Side Comparison

Dynamis Therapeutics, Inc. Immunic Therapeutics
Founded
1997 older 2016
Headquarters
Jenkintown, United States United States
Employees
2-10 91 larger
Industry
Biotechnology Biotechnology, Health and Wellness, Life Sciences
Funding Stage
Seed Post Ipo Equity
Total Funding
Not tracked yet $520.00M
Funding Rounds
1 10
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biopharma, Chronic Inflammation, Small Molecule Therapies, Drug Development, Enzyme Inhibition, AGEs, Oxidative Stress, Inflammatory Cytokines, Disease Treatment, 3-deoxyglucosone Pathway, Biopharmaceuticals, Innovative Therapies Small Molecule Therapies, Chronic Inflammatory Diseases, Autoimmune Diseases, Clinical Pipeline, Oral Administration, Nasdaq Listed, Drug Development, Precision Medicine, Pharmaceuticals, Immunology, Autoimmune Disorders
Website
dynamis-therapeutics.com imux.com
Dynamis Therapeutics, Inc. logo

About Dynamis Therapeutics, Inc.

Dynamis Pharmaceuticals, Inc. is a pioneering biopharma enterprise founded in 1997 with the slogan "Pioneering the future of chronic inflammation treatment through innovative small molecule therapies." Specializing in the Biotechnology industry, the company is headquartered in the United States. Dyn...

Immunic Therapeutics logo

About Immunic Therapeutics

Immunic Therapeutics is a biotechnology company founded in 2016 and headquartered in the United States. The company's focus lies in the development of small molecule therapies for chronic inflammatory and autoimmune diseases. Immunic, listed on Nasdaq under the ticker symbol IMUX, boasts a clinical...

We will tell you when either one moves

BounceWatch watches Dynamis Therapeutics, Inc. and Immunic Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Dynamis Therapeutics,... and Immunic Therapeutics — by email.

Frequently Asked Questions

Dynamis Therapeutics, Inc. — Pioneering the future of chronic inflammation treatment through innovative small molecule therapies.. Immunic Therapeutics — Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Dynamis Therapeutics, Inc. has raised undisclosed funding while Immunic Therapeutics has raised $520.00M.
Dynamis Therapeutics, Inc. and Immunic Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Dynamis Therapeutics, Inc. with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Dynamis Therapeutics, Inc. on 12 Sep 2024, and Immunic Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy